share_log

Vivos Therapeutics | EFFECT: Others

SEC ·  Aug 8 18:11
Summary by Futu AI
Vivos Therapeutics, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of August 7, 2024, at 4:30 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This effectiveness indicates that Vivos Therapeutics has met the necessary regulatory requirements to move forward with its securities offerings.
Vivos Therapeutics, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of August 7, 2024, at 4:30 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This effectiveness indicates that Vivos Therapeutics has met the necessary regulatory requirements to move forward with its securities offerings.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.